Vertex Pharmaceuticals Incorporated <VRTX.O>: Morgan Stanley resumes coverage with Overweight rating; target price $665
VRTX•Related News
BP appoints former Balfour Beatty CEO Ian Tyler as chair
BP•
U.S. stocks on the move-TScan Therapeutics, EOS Energy, Brown-Forman Corp
SPY•
Cohen & Steers fund manager lifts Prologis stake to 2.93%
PLD•
LPG shipper StealthGas Q2 revenue slips on lower vessel count
GASS•
Saudi Arabia says Iran attacked vessel in Hormuz, killing two sailors
XLE•